Kelley RK, Ueno M, Yoo C, Finn RS, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023 Apr 14:S0140-6736(23)00727-4. doi: 10.1016/S0140-6736(23)00727.
PMID: 37075781